Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Show Description +

How should you manage a patient with acute vision loss from new-onset wet AMD in his better-seeing eye? Host David Miller, MD, sits down with Ehsan Rahimy, MD, and Esther Kim, MD, to discuss how initial agents are selected, how insurance mandates shape real-world choices, and why some scenarios warrant unusually early follow-up.

Posted: 11/10/2025

Keywords:

Bevacizumab

•

aflibercept

•

Eylea

•

eylea hd

•

regeneron

•

Neovascular Age-Related Macular Degeneration

•

Age-Related Macular Degeneration (AMD)

•

Avastin

•

switching

Up Next

Name: Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD
Uploaded: 2025-11-10T19:00:03+00:00
Description: How should you manage a patient with acute vision loss from new-onset wet AMD in his better-seeing eye? Host David Miller, MD, sits down with Ehsan Rahimy, MD, and Esther Kim, MD, to discuss how initial agents are selected, how insurance mandates shape real-world choices, and why some scenarios warrant unusually early follow-up.